Drugs / Cefoperazone
Cefoperazone
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | CEFOBID | — | 1982-11-18 | fda.gov ↗ |
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00360607 | Jul 2004 → Apr 2005 | infectious disease | Pfizer | Completed | No outcome recorded |
Also used as a comparator or background therapy in 5 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT02099240 Comparator | Mar 2014 → Nov 2018 | osteomyelitis | University of Louisville | Terminated | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT02060149 Background | Mar 2014 → Mar 2015 | pneumonia | Xijing Hospital | Unknown | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT01601093 Comparator | Nov 2011 → Aug 2022 | respiratory tract infectious disorder, urinary tract infection | Xiangbei Welman Pharmaceutical Co., Ltd | Suspended | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT01992198 Comparator | Jul 2012 → Dec 2015 | acute necrotizing pancreatitis | Erzhen Chen | Unknown | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT03436719 Background | Nov 2017 → Jul 2020 | rectal cancer | State Scientific Centre of Coloproctology, Russian Federation | Unknown | No outcome recorded |
Evidence & citations 16 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | cefoperazone | “Cefoperazone/ sulbactam 3.0g（intravenous infusion, q8h or q6h) combined with minocycline doxycycline 100mg (oral, q12h).” NCT02060149 ↗5“Cefoperazone - 1000 mg intravenously for 30-90 minutes before surgery” NCT03436719 ↗ “Cefoperazone” NCT02099240 ↗ |
| Known as | Cefobid | ChEMBL registry synonym — accepted as the source's own label CHEMBL507674 ↗ |
| Known as | Cefobis | ChEMBL registry synonym — accepted as the source's own label CHEMBL507674 ↗ |
| Known as | Cefoperazona | ChEMBL registry synonym — accepted as the source's own label CHEMBL507674 ↗ |
| Known as | Cefoperazone (as sodium) | ChEMBL registry synonym — accepted as the source's own label CHEMBL507674 ↗ |
| Known as | CEFOPERAZONE DIHYDRATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL507674 ↗ |
| Known as | Cefoperazone Sodium | “Magnex (Sulbactam Sodium/Cefoperazone Sodium 1:1) Pfizer Ltd.” NCT00360607 ↗ |
| Known as | Cefoperazone sodium component of sulperazone | ChEMBL registry synonym — accepted as the source's own label CHEMBL507674 ↗ |
| Known as | Cefoperazone sodium salt | ChEMBL registry synonym — accepted as the source's own label CHEMBL507674 ↗ |
| Known as | CP-52,640-2 | ChEMBL registry synonym — accepted as the source's own label CHEMBL507674 ↗ |
| Known as | NSC-758173 | ChEMBL registry synonym — accepted as the source's own label CHEMBL507674 ↗ |
| Known as | Peracef | ChEMBL registry synonym — accepted as the source's own label CHEMBL507674 ↗ |
| Known as | Sodium cefoperazone | ChEMBL registry synonym — accepted as the source's own label CHEMBL507674 ↗ |
| Known as | T-1551 | ChEMBL registry synonym — accepted as the source's own label CHEMBL507674 ↗ |
| Modality | Small molecule | “beta-lactam/beta-lactamase inhibitor combination cefoperazone-sulbactam” PMID 18570578 ↗ Jun 2008 |
| Route | Intravenous | “Cefoperazone 2g, iv, bid” NCT01601093 ↗ |